Pacer Advisors, Inc. Arcturus Therapeutics Holdings Inc. Transaction History

Pacer Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$24.35 - $44.39 $6,988 - $12,739	-287 Reduced 39.26%	444 $10,000
Q1 2024 May 10, 2024	BUY	$31.23 - $42.99 $22,829 - $31,425	731 New	731 $24,000
Q2 2021 Jul 21, 2021	SELL	$25.79 - $42.11 $40,696 - $66,449	-1,578 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$38.75 - $86.92 $12,865 - $28,857	332 Added 26.65%	1,578 $65,000
Q4 2020 Jan 20, 2021	BUY	$34.61 - $123.66 $43,124 - $154,080	1,246 New	1,246 $54,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.